Richard Eglen Joins PerkinElmer
PerkinElmer Inc., a Wellesly, Mass.-based global provider of technology for markets including photonics, life and analytical sciences, optoelectronics and fluid sciences, announced today that Richard Eglen has joined the company as vice president and general manager, discovery and research reagents, for PerkinElmer's Life & Analytical Sciences unit. Eglen joins PerkinElmer from DiscoveRx, where he was chief scientific officer and executive vice president for research and development. Before that, he worked for more than 20 years in executive positions in the pharmaceutical, diagnostic and biotech industries. Eglen has a PhD in molecular pharmacology from Trent University in Nottingham, England. He has been published in more than 250 scientific papers and books and holds several patents, many of which focus on key drug discovery targets such as GPCRs, kinases and ion channels. He also holds several patents relating to novel technologies for enabling drug discovery and other types of research. He serves on numerous journal editorial boards and is on the board of the Society for BioMolecular Sciences.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024